Citation only
via OpenAlex
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes
Simona Bo, Paolo Cavallo‐Perin, L. Gentile, Elena Repetti, Gianfranco Pagano
European Journal of Clinical Investigation · 2001 · ▲ 162 citations
Abstract
BACKGROUND AND DESIGN: Conflicting data exist about uric acid levels in type 2 diabetes mellitus, as low levels were found in diabetic patients, while elevated serum uric acid is a feature of hyperinsulinemia and impaired glucose tolerance. The present study was addressed to evaluate the relation between uric acid and metabolic parameters, creatinine clearance and albumin excretion rate in a cohort of type 2 diabetic patients. RESULTS: Hyperuricemic patients were older and had higher values of body mass index (BMI), systolic and diastolic blood pressure, triglycerides, albumin excretion rate, C-peptide and prevalence of hypertension, metabolic syndrome and macroalbuminuria and lower values of high-density lipoprotein (HDL)-cholesterol, creatinine clearance and glycated haemoglobin (HbA1c). The correlations between uric acid levels and triglycerides, BMI, systolic blood pressure, albumin excretion rate, C-peptide, creatinine clearance, HDL-cholesterol and HbA1c remained significant in a multiple regression analysis after adjustment for age, sex and duration of diabetes. After performing multiple logistic regression analyses, uric acid levels were independently associated with hypertension [odds ratio (OR) = 1.8; 95% confidence interval (CI) 1.6--2], after adjustment for age, sex, duration of diabetes and macroalbuminuria (OR = 1.5; 95% CI 1.1--2.0), after adjustment for age, sex, HbA1c levels, creatinine clearance, duration of diabetes and blood pressure levels and the metabolic syndrome (OR = 1.6; 95% CI 1.5--1.8), after adjustment for age, sex and creatinine clearance. CONCLUSIONS: In type 2 diabetes, hyperuricemia seems to be associated with the insulin-resistant syndrome and with early onset or increased progression to overt nephropathy, while hypouricemia is associated with worse metabolic control, hyperfiltration and a late onset or decreased progression to overt nephropathy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1046/j.1365-2362.2001.00812.x
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Bo, S., Cavallo‐Perin, P., Gentile, L., Repetti, E., & Pagano, G. (2001). Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. <em>European Journal of Clinical Investigation</em>. https://doi.org/10.1046/j.1365-2362.2001.00812.x
Vancouver
Bo S, Cavallo‐Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. European Journal of Clinical Investigation. 2001. doi:10.1046/j.1365-2362.2001.00812.x.
BibTeX
@article{simona2001Hypour,
title = {Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes},
author = {Simona Bo and Paolo Cavallo‐Perin and L. Gentile and Elena Repetti and Gianfranco Pagano},
journal = {European Journal of Clinical Investigation},
year = {2001},
doi = {10.1046/j.1365-2362.2001.00812.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Care 2013
Open access · CC-BY
Food Insecurity and Metabolic Control Among U.S. Adults With Diabetes
Diabetes/Metabolism Research and Reviews 2001
Citation only
Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study
Cardiovascular Diabetology 2011
Open access · CC-BY
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes
Journal of Periodontology 2010
Citation only
Association of Periodontal Parameters With Metabolic Level and Systemic Inflammatory Markers in Patients With Type 2 Diabetes
Metabolic Syndrome and Related Disorders 2007
Citation only
Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 2023
Open access · US-GOV